Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/03/02 Updated
Market Cap: $878.2M (¥137.0B)
Stock Price: $28.81 (¥4,495)
Exchange Rate: 1 USD = ¥156.01

Monthly Sales Report for February 2026 Fiscal Year Ending June

For February 2026, total store sales increased 7.2% year-over-year, existing store sales were flat at 100.0%, with 3 new store openings and no closures.

Importance:
Page Updated: February 27, 2026
IR Disclosure Date: February 27, 2026

Key Figures

  • Total Store Sales Year-over-Year: 107.2% (February 2026)
  • Existing Store Sales Year-over-Year: 100.0% (February 2026)
  • Total Number of Stores: 503 (February 2026)

AI要約

Overview of Monthly Sales Report

According to the monthly sales report for February 2026, total store sales increased 7.2% year-over-year, while existing store sales remained flat at 100.0% year-over-year. Customer traffic rose slightly by 0.3% year-over-year, whereas spending per customer decreased marginally to 99.7%. There were 3 new store openings and no store closures, resulting in a total of 503 stores. These figures are preliminary based on the monthly closing data and may differ from the official financial results.

Store Expansion and Future Outlook

New stores are being opened as standardized regular stores of approximately 300 tsubo, with an unknown number of renovated stores as the company continues to push store standardization. While existing store sales remain flat, the increase in customer traffic alongside a slight decrease in spending per customer puts focus on future sales strategies. Monthly sales reports are disclosed at the end of each month, allowing investors to continuously monitor business trends.

Total Sales YoY (All Stores) Trend (Feb 2025 - Feb 2026)

Sales YoY (Existing Stores) Trend (Feb 2025 - Feb 2026)

Customer Traffic YoY (Existing Stores) Trend (Feb 2025 - Feb 2026)

Spending Per Customer YoY (Existing Stores) Trend (Feb 2025 - Feb 2026)

Total Number of Stores Trend (Feb 2025 - Feb 2026)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.